Vaccines for epidemic infections and the role of CEPI
- PMID: 28375764
- PMCID: PMC5718831
- DOI: 10.1080/21645515.2017.1306615
Vaccines for epidemic infections and the role of CEPI
Abstract
The author reviews the foundation of the Coalition for Epidemic Preparedness and Innovations and the choices it has made for funding of vaccine development against epidemic diseases. He comments on those decisions as well as proposing how CEPI could remain relevant for the long term.
Keywords: MERS; Nipah; chikungunya; commercialization; development; ebola; emerging infections; field delivery; infectious disease; lassa.
References
-
- Plotkin SA, Mahmoud AA, Farrar J. Establishing a Global Vaccine-Development Fund. N Engl J Med 2015; 373(4:297-300; PMID:26200974; http://dx.doi.org/ 10.1056/NEJMp1506820 - DOI - PubMed
-
- Abushouk AI, Negida A, Ahmed H. An updated review of Zika virus. J Clin Virol 2016; 84:53-8; http://dx.doi.org/ 10.1016/j.jcv.2016.09.012 - DOI - PubMed
-
- Pierson TC, Graham BS. Zika virus: Immunity and vaccine development. Cell 2016; 167(3):625-31; PMID:27693357; http://dx.doi.org/ 10.1016/j.cell.2016.09.020 - DOI - PMC - PubMed
-
- Pronker ES, Weenen TC, Commandeur HR, Osterhaus AD, Claassen HJ. The gold industry standard for risk and cost of drug and vaccine development revisited. Vaccine 2011; 29(35):5846-9; PMID:21722688; http://dx.doi.org/ 10.1016/j.vaccine.2011.06.051 - DOI - PubMed
-
- MacNeil JR, Rubin L, Folaranmi T, Ortega-Sanchez IR, Patel M, Martin SW. Use of serogroup B meningococcal vaccines in adolescents and young adults: Recommendations of the advisory committee on immunization practices, 2015. MMWR Morb Mortal Wkly Rep 2015; 64(41):1171-6; PMID:26492381; http://dx.doi.org/ 10.15585/mmwr.mm6441a3 - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical